Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-024930
Filing Date
2024-10-09
Accepted
2024-10-09 16:21:47
Documents
2
Period of Report
2024-10-08

Document Format Files

Seq Description Document Type Size
1 form3-10092024_081043.html 3  
1 form3-10092024_081043.xml 3 1658
2 ex24-10092024_081044.htm EX-24 5454
  Complete submission text file 0001415889-24-024930.txt   8535
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Degnan Chris (Reporting) CIK: 0001741968 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38079 | Film No.: 241363023